• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOLOGIC, INC MYOSURE HYSTEROSCOPIC TISSUE REMOVAL SYSTEM; UTERINE TISSUE REMOVAL SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOLOGIC, INC MYOSURE HYSTEROSCOPIC TISSUE REMOVAL SYSTEM; UTERINE TISSUE REMOVAL SYSTEM Back to Search Results
Catalog Number 10-401
Device Problems Contamination (1120); Device Operates Differently Than Expected (2913)
Patient Problem Sepsis (2067)
Event Type  Injury  
Manufacturer Narrative
Lot and serial number of the disposable device not provided by the complainant, therefore the expiration date is not known.The device is not being returned therefore, a failure analysis of the complaint device cannot be completed.Lot number of the disposable device not provided by the complainant, therefore the manufacture date is not known.Device history record (dhr) review was unable to be conducted for the disposable device as the identification numbers were not provided by the complainant.According to the instructions for use (ifu) warnings: to avoid perforation, keep the device tip under direct visualization and exercise care at all times when maneuvering it or cutting it close to the uterine wall.Never use the device tip as a probe or dissecting tool.(b)(4).
 
Event Description
It was reported at the beginning of a myosure procedure for uterine tissue removal on (b)(6) 2017 the physician noted the patient experienced some bleeding.The physician continued with the procedure.The patients fluid deficit started to rise under 2500 cc and the physician aborted the procedure.The physician removed the hysteroscope and disposable device; no bleeding was exhibited.The patient was admitted into the hospital overnight for observation and developed "a fever that night and was septic".The patient was transferred to intensive care unit (icu) for three days.The patients pathology came back with bowel in it.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MYOSURE HYSTEROSCOPIC TISSUE REMOVAL SYSTEM
Type of Device
UTERINE TISSUE REMOVAL SYSTEM
Manufacturer (Section D)
HOLOGIC, INC
250 campus drive
marlborough MA 01752
Manufacturer Contact
sidra piracha
250 campus drive
marlborough, MA 01752
5082638884
MDR Report Key6804909
MDR Text Key83062976
Report Number1222780-2017-00207
Device Sequence Number1
Product Code HIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K100559
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 07/21/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Physician
Device Catalogue Number10-401
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 07/21/2017
Initial Date FDA Received08/18/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
AQUILEX FLUID MANAGMENT SYSTEM: SERIAL # UNK; MYOSURE CONTROL UNIT: SERIAL NUMBER UNKNOWN
Patient Outcome(s) Hospitalization; Required Intervention;
-
-